Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-24-000150 General Corporate
Debt relative to revenue 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
192.50% · OPTIONAL · VALID
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.37% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.08% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
8.23% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
56.28% · OPTIONAL · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
5.28% · CORE · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.77% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 105.30%
Current 192.50%
Delta 87.21% Capex Intensity Decreased
Previous 7.16%
Current 5.37%
Delta -1.79% Cash Generation Increased
Previous 5.76%
Current 21.08%
Delta 15.32% Growth Decreased
Previous 13.66%
Current 8.23%
Delta -5.43% Inventory Pressure Decreased
Previous 61.07%
Current 56.28%
Delta -4.79% Profitability Decreased
Previous 10.11%
Current 5.28%
Delta -4.83% Sbc Intensity Decreased
Previous 1.11%
Current 0.77%
Delta -0.35% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.